A case of lymphocytic myocarditis in a patient treated with an immune checkpoint inhibitor, a recent class of chemotherapy agents

A case of lymphocytic myocarditis in a patient treated with an immune checkpoint inhibitor, a recent class of chemotherapy agents

Chemotherapy-associated cardiotoxicity is a common adverse event. Immune checkpoint inhibitors (ICI) – a new class of monoclonal antibodies – have revolutionized the management of various diseases. Their use is expected to increase in the near future and their cardiac side effects have been increasi...

Full description

Bibliographic Details
Main Authors: Tatiana Duarte, Cátia Costa, Sara Gonçalves, Luís Raposo, António Ferreira, Catarina Albuquerque, Nuno Vau, Rui Caria
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Revista Portuguesa de Cardiologia
Subjects:
Cardiotoxicidade
Inibidores dos checkpoint imunes
Pembrolizumab
Miocardite linfocítica
Online Access:http://www.sciencedirect.com/science/article/pii/S0870255122004590

Similar Items

Similar Items